PT1183046E - Derivado de aminotetralina para a terapia de doencas cardiovasculares - Google Patents

Derivado de aminotetralina para a terapia de doencas cardiovasculares

Info

Publication number
PT1183046E
PT1183046E PT00935184T PT00935184T PT1183046E PT 1183046 E PT1183046 E PT 1183046E PT 00935184 T PT00935184 T PT 00935184T PT 00935184 T PT00935184 T PT 00935184T PT 1183046 E PT1183046 E PT 1183046E
Authority
PT
Portugal
Prior art keywords
therapy
cardiovascular diseases
aminotetralin derivatives
aminotetralin
left ventricular
Prior art date
Application number
PT00935184T
Other languages
English (en)
Inventor
Stefano Bongrani
Paolo Chiesi
Maurizio Civelli
Alberto Umile
Roberta Razzetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/328,434 external-priority patent/US6103760A/en
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PT1183046E publication Critical patent/PT1183046E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT00935184T 1999-06-09 2000-06-07 Derivado de aminotetralina para a terapia de doencas cardiovasculares PT1183046E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/328,434 US6103760A (en) 1995-03-17 1999-06-09 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (1)

Publication Number Publication Date
PT1183046E true PT1183046E (pt) 2003-12-31

Family

ID=23280968

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00935184T PT1183046E (pt) 1999-06-09 2000-06-07 Derivado de aminotetralina para a terapia de doencas cardiovasculares

Country Status (27)

Country Link
US (2) US6576671B1 (pt)
EP (1) EP1183046B1 (pt)
JP (1) JP2003501483A (pt)
KR (1) KR20020005772A (pt)
CN (1) CN1354676A (pt)
AT (1) ATE248607T1 (pt)
AU (1) AU766230B2 (pt)
BR (1) BR0012121A (pt)
CA (1) CA2376715A1 (pt)
CZ (1) CZ20014406A3 (pt)
DE (1) DE60004996T2 (pt)
DK (1) DK1183046T3 (pt)
EA (1) EA003830B1 (pt)
EE (1) EE200100663A (pt)
ES (1) ES2206240T3 (pt)
HK (1) HK1044279B (pt)
HU (1) HUP0201650A2 (pt)
IL (1) IL146962A0 (pt)
MA (1) MA26796A1 (pt)
MX (1) MXPA01012638A (pt)
NO (1) NO20016000L (pt)
NZ (1) NZ515727A (pt)
PL (1) PL352119A1 (pt)
PT (1) PT1183046E (pt)
SK (1) SK18012001A3 (pt)
TR (1) TR200103526T2 (pt)
ZA (1) ZA200110091B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
EP1500392A1 (en) * 2003-07-24 2005-01-26 CHIESI FARMACEUTICI S.p.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
EP1183046A1 (en) 2002-03-06
MA26796A1 (fr) 2004-12-20
IL146962A0 (en) 2002-08-14
DE60004996D1 (de) 2003-10-09
EA003830B1 (ru) 2003-10-30
PL352119A1 (en) 2003-07-28
HK1044279B (zh) 2004-01-16
ATE248607T1 (de) 2003-09-15
NZ515727A (en) 2003-06-30
US20030207944A1 (en) 2003-11-06
NO20016000L (no) 2002-02-11
CA2376715A1 (en) 2000-12-21
US6576671B1 (en) 2003-06-10
DE60004996T2 (de) 2004-07-22
DK1183046T3 (da) 2004-01-05
EE200100663A (et) 2003-04-15
CZ20014406A3 (cs) 2002-04-17
JP2003501483A (ja) 2003-01-14
EP1183046B1 (en) 2003-09-03
AU5076500A (en) 2001-01-02
BR0012121A (pt) 2002-05-14
AU766230B2 (en) 2003-10-09
CN1354676A (zh) 2002-06-19
KR20020005772A (ko) 2002-01-17
HUP0201650A2 (hu) 2002-12-28
TR200103526T2 (tr) 2002-04-22
SK18012001A3 (sk) 2002-04-04
EA200101159A1 (ru) 2002-06-27
ZA200110091B (en) 2002-12-09
NO20016000D0 (no) 2001-12-07
MXPA01012638A (es) 2002-07-22
ES2206240T3 (es) 2004-05-16
HK1044279A1 (en) 2002-10-18

Similar Documents

Publication Publication Date Title
NO2012015I1 (no) Dapoxetine i en hver form beskyttet av basis patent nr 330562
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
MY119375A (en) Treatment of tinnitus using neuroprotective agents
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
NO20003313L (no) Terapeutiske midler
PT1183046E (pt) Derivado de aminotetralina para a terapia de doencas cardiovasculares
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
EP1331004A3 (en) Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
NO20003785L (no) Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
JO2127B1 (en) How to prevent asthma